New York State Common Retirement Fund decreased its position in shares of Chemed Co. (NYSE:CHE - Free Report) by 6.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,025 shares of the company's stock after selling 1,400 shares during the period. New York State Common Retirement Fund owned 0.13% of Chemed worth $10,609,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors also recently bought and sold shares of CHE. UMB Bank n.a. grew its stake in Chemed by 300.0% during the 4th quarter. UMB Bank n.a. now owns 52 shares of the company's stock worth $28,000 after buying an additional 39 shares during the last quarter. Trust Co. of Vermont acquired a new stake in shares of Chemed during the fourth quarter worth $34,000. Allworth Financial LP grew its holdings in shares of Chemed by 2,057.1% during the fourth quarter. Allworth Financial LP now owns 151 shares of the company's stock valued at $83,000 after buying an additional 144 shares during the last quarter. Farther Finance Advisors LLC raised its stake in Chemed by 2,314.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company's stock worth $203,000 after acquiring an additional 324 shares during the last quarter. Finally, KBC Group NV raised its position in Chemed by 11.5% during the 3rd quarter. KBC Group NV now owns 378 shares of the company's stock worth $227,000 after buying an additional 39 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
A number of research firms have weighed in on CHE. StockNews.com lowered Chemed from a "buy" rating to a "hold" rating in a research note on Thursday. Royal Bank of Canada lowered their price objective on Chemed from $697.00 to $633.00 and set an "outperform" rating on the stock in a research report on Tuesday, November 5th.
View Our Latest Stock Report on CHE
Chemed Stock Up 2.4 %
Shares of NYSE:CHE traded up $14.34 during trading on Friday, reaching $600.46. 141,070 shares of the company's stock traded hands, compared to its average volume of 96,193. The firm has a market cap of $9.04 billion, a PE ratio of 30.34, a P/E/G ratio of 2.15 and a beta of 0.48. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $654.62. The company has a 50-day simple moving average of $545.15 and a 200-day simple moving average of $563.27.
Chemed Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, March 14th. Investors of record on Monday, February 24th will be issued a $0.50 dividend. This represents a $2.00 annualized dividend and a yield of 0.33%. The ex-dividend date of this dividend is Monday, February 24th. Chemed's payout ratio is presently 10.11%.
Insider Buying and Selling at Chemed
In other news, VP Brian C. Judkins acquired 145 shares of Chemed stock in a transaction that occurred on Monday, December 30th. The stock was purchased at an average cost of $519.50 per share, with a total value of $75,327.50. Following the purchase, the vice president now owns 1,678 shares in the company, valued at $871,721. This trade represents a 9.46 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 3.32% of the company's stock.
Chemed Profile
(
Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Read More

Before you consider Chemed, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chemed wasn't on the list.
While Chemed currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.